Neurology and therapy

Keyphrases

Publications

2023

Margherita Fabbri, Raquel Barbosa, Olivier Rascol
Off-time Treatment Options for Parkinson's Disease. Neurology and therapy (2023)
Borje Darpo, Michal Geva, Georg Ferber, Yigal Paul Goldberg, Andres Cruz-Herranz, Munish Mehra, Richard Kovacs, Michael R Hayden
Pridopidine Does Not Significantly Prolong the QTc Interval at the Clinically Relevant Therapeutic Dose. Neurology and therapy (2023)
Vicente Villanueva, Jesús Artal, Clara-Isabel Cabeza-Alvarez, Dulce Campos, Ascensión Castillo, Gerardo Flórez, Manuel Ángel Franco-Martín, Maria Paz Garcia-Portilla, Beatriz G Giráldez, Francisco Gotor, Luis Gutiérrez-Rojas, Albert Molins Albanell, Gonzalo Paniagua, Luis Pintor-Pérez, Juan José Poza, Teresa Rubio-Granero, Manuel Toledo, Diego Tortosa-Conesa, Juan Rodríguez-Uranga, Julio Bobes
Proposed Recommendations for the Management of Depression in Adults with Epilepsy: An Expert Consensus. Neurology and therapy (2023)
Margherita Fabbri, Raquel Barbosa, Olivier Rascol
Off-time Treatment Options for Parkinson's Disease. Neurology and therapy (2023)
Margherita Fabbri, Raquel Barbosa, Olivier Rascol
Correction to: Off-time Treatment Options for Parkinson's Disease. Neurology and therapy (2023)
Enrico Bentivegna, Dilara Onan, Paolo Martelletti
Unmet Needs in Preventive Treatment of Migraine. Neurology and therapy (2023)
Mirla Avila, Yuanyuan Tan, Roberto Hernandez, Hafsa Zuberi, Victor M Rivera
Correction to: Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: Onset Following Acute COVID-19 Infection, a Case Series. Neurology and therapy (2023)
Jonathan D Santoro, Jennifer Gould, Zoya Panahloo, Ella Thompson, Julia Lefelar, Jacqueline Palace
Patient Pathway to Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Findings from a Multinational Survey of 204 Patients. Neurology and therapy (2023)
Amir Abbas Tahami Monfared, Yaakov Stern, Stephen Doogan, Michael Irizarry, Quanwu Zhang
Understanding Barriers Along the Patient Journey in Alzheimer's Disease Using Social Media Data. Neurology and therapy (2023)
Carla Abdelnour, Maria Camila Gonzalez, Lucy L Gibson, Kathleen L Poston, Clive G Ballard, Jeffrey L Cummings, Dag Aarsland
Dementia with Lewy Bodies Drug Therapies in Clinical Trials: Systematic Review up to 2022. Neurology and therapy (2023)
Marco Alfonso Capobianco, Marius Ringelstein, Carly Welsh, Patricia Lobo, Gabrielle deFiebre, Marco Lana-Peixoto, Jiawei Wang, Ju-Hong Min, Dean M Wingerchuk
Characterization of Disease Severity and Stability in NMOSD: A Global Clinical Record Review with Patient Interviews. Neurology and therapy (2023)
Jingchen Li, Zhiyong Li, Lin Zhao, Yuanyu Wang, Jiankai Yang, Yan Feng, Xiaowei Zhang, Xiuwen Wu
Optimizing The Timing of Stereotactic Minimally Invasive Drainage for Hypertensive Intracerebral Hemorrhage. Neurology and therapy (2023)
Lilyana Amezcua, Yang Mao-Draayer, Wendy S Vargas, Rebecca Farber, Sara Schaefer, Filipe Branco, Sarah M England, Nicholas Belviso, James B Lewin, Jason P Mendoza, Sai L Shankar, null null
Efficacy of Dimethyl Fumarate in Young Adults with Relapsing-Remitting Multiple Sclerosis: Analysis of the DEFINE, CONFIRM, and ENDORSE Studies. Neurology and therapy (2023)
Amir Abbas Tahami Monfared, Weicheng Ye, Aditya Sardesai, Henri Folse, Ameya Chavan, Elena Aruffo, Quanwu Zhang
A Path to Improved Alzheimer's Care: Simulating Long-Term Health Outcomes of Lecanemab in Early Alzheimer's Disease from the CLARITY AD Trial. Neurology and therapy (2023)
Celia Oreja-Guevara, Aintzane Rabanal, Corazón Hernández Rodríguez, Yolanda Aladro Benito, Mar Mendibe Bilbao, Inés Gónzalez-Suarez, José Luis Gómez-Palomares
Assisted Reproductive Techniques in Multiple Sclerosis: Recommendations from an Expert Panel. Neurology and therapy (2023)
Dana B DiBenedetti, Heather Menne, Russ Paulsen, Holly B Krasa, George Vradenburg, Meryl Comer, Leigh F Callahan, John Winfield, Michele Potashman, Kim Heithoff, Ann Hartry, Dorothee Oberdhan, Hilary Wilson, Deborah L Hoffman, Dan Wieberg, Ian N Kremer, Geraldine A Taylor, James M Taylor, Debra Lappin, Allison D Martin, Brett Hauber, Carla Romano
Technical Review of Clinical Outcomes Assessments Across the Continuum of Alzheimer's Disease. Neurology and therapy (2023)
François-Xavier Chalet, Orestis Briasoulis, Eric Julian Manalastas, Darren A Talbot, Juliette C Thompson, Robert Loch Macdonald
Clinical Burden of Angiographic Vasospasm and Its Complications After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review. Neurology and therapy (2023)
Aliya Jaber, Meera Patel, Andrew Sylvester, Mary Yarussi, J Tamar Kalina, Jason P Mendoza, Robin L Avila, Matthew A Tremblay
COVID-19 Vaccine Response in People with Multiple Sclerosis Treated with Dimethyl Fumarate, Diroximel Fumarate, Natalizumab, Ocrelizumab, or Interferon Beta Therapy. Neurology and therapy (2023)
Judith Bluvstein, Susanna Wenniger
Two Perspectives on Dravet Syndrome: Viewpoints from the Clinician and the Caregiver. Neurology and therapy (2023)
Jai Perumal, Roumen Balabanov, Laura Balcer, Steven Galetta, Zhaonan Sun, Hanyue Li, Danette Rutledge, Robin L Avila, Robert J Fox
Long-Term Effectiveness and Safety of Natalizumab in African American and Hispanic/Latino Patients with Early Relapsing-Remitting Multiple Sclerosis: STRIVE Data Analysis. Neurology and therapy (2023)
Gustavo Saposnik, Gonzalo Sánchez-Benavidez, Elena García-Arcelay, Emilio Franco-Macías, Catalina Bensi, Sebastián Carmelingo, Ricardo F Allegri, David A Pérez-Martínez, Jorge Maurino
Design of a Non-Interventional Study to Assess Neurologists' Perspectives and Pharmacological Treatment Decisions in Early Alzheimer's Disease. Neurology and therapy (2023)
Claudia A Chiriboga, Claudio Bruno, Tina Duong, Dirk Fischer, Eugenio Mercuri, Janbernd Kirschner, Anna Kostera-Pruszczyk, Birgit Jaber, Ksenija Gorni, Heidemarie Kletzl, Imogen Carruthers, Carmen Martin, Francis Warren, Renata S Scalco, Kathryn R Wagner, Francesco Muntoni, null null
Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study. Neurology and therapy (2023)
Katarina M Doma, Erin Diane Lewis, Jane M Barracato, Lauren R Brink, Alejandra A Gratson, Neeraj Pandey, David C Crowley, Malkanthi Evans
A Randomized, Double-Blind, Placebo-Controlled, Parallel Study Investigating the Efficacy of a Whole Coffee Cherry Extract and Phosphatidylserine Formulation on Cognitive Performance of Healthy Adults with Self-Perceived Memory Problems. Neurology and therapy (2023)
Yu-Luan Chen, Hironobu Tsukada, Snezana Milanovic, Lei Shi, Yan Li, Yongcai Mao, Kenneth S Koblan, Gerald R Galluppi
Comparative Bioequivalence of Tablet and Capsule Formulations of Ulotaront and the Effect of Food on the Pharmacokinetics of the Tablet Form in Humans. Neurology and therapy (2023)
Ju-Hong Min, Marco Capobianco, Carly Welsh, Patricia Lobo, Gabrielle deFiebre, Marco Lana-Peixoto, Dean M Wingerchuk, Jiawei Wang, Marius Ringelstein
Understanding Treatment Decisions in Neuromyelitis Optica Spectrum Disorder: A Global Clinical Record Review with Patient Interviews. Neurology and therapy (2023)
Michael J Soileau, Fernando L Pagan, Alfonso Fasano, Ramon Rodriguez-Cruz, Connie H Yan, Niodita R Gupta, Christie L Teigland, Zulkarnain Pulungan, Jill K Schinkel, Prasanna L Kandukuri, Omar A Ladhani, Mustafa S Siddiqui
Comparative Effectiveness of Carbidopa/Levodopa Enteral Suspension and Deep Brain Stimulation on Pill Burden Reduction in Medicare Fee-for-Service Patients with Advanced Parkinson's Disease. Neurology and therapy (2023)

volume 12, number 3, 2023

Dominika Miszewska, Katarzyna Kotulska, Aleksandra Duda, Sergiusz Jozwiak
Effect of mTOR Inhibitors in Epilepsy Treatment in Children with Tuberous Sclerosis Complex Under 2 Years of Age. Neurology and therapy 12 (3) (2023)
Beibei Liang, Jin Wang, Guanxuanzi Zhang, Rui Wang, Yun Cai
Safety, Tolerability and Pharmacokinetics of Single-Dose Oral SYHA1402 in Healthy Chinese Subjects. Neurology and therapy 12 (3) (2023)
Yijie Feng, Yiqin Cui, Jianing Jin, Siyi Huang, Jia Wei, Mei Yao, Dongming Zhou, Shanshan Mao
The Alterations of Gut Microbiome and Lipid Metabolism in Patients with Spinal Muscular Atrophy. Neurology and therapy 12 (3) (2023)
Dominika Miszewska, Katarzyna Kotulska, Aleksandra Duda, Sergiusz Jozwiak
Effect of mTOR Inhibitors in Epilepsy Treatment in Children with Tuberous Sclerosis Complex Under 2 Years of Age. Neurology and therapy 12 (3) (2023)
Yijie Feng, Yiqin Cui, Jianing Jin, Siyi Huang, Jia Wei, Mei Yao, Dongming Zhou, Shanshan Mao
The Alterations of Gut Microbiome and Lipid Metabolism in Patients with Spinal Muscular Atrophy. Neurology and therapy 12 (3) (2023)
Beibei Liang, Jin Wang, Guanxuanzi Zhang, Rui Wang, Yun Cai
Safety, Tolerability and Pharmacokinetics of Single-Dose Oral SYHA1402 in Healthy Chinese Subjects. Neurology and therapy 12 (3) (2023)
Yijie Feng, Yiqin Cui, Jianing Jin, Siyi Huang, Jia Wei, Mei Yao, Dongming Zhou, Shanshan Mao
The Alterations of Gut Microbiome and Lipid Metabolism in Patients with Spinal Muscular Atrophy. Neurology and therapy 12 (3) (2023)
Beibei Liang, Jin Wang, Guanxuanzi Zhang, Rui Wang, Yun Cai
Safety, Tolerability and Pharmacokinetics of Single-Dose Oral SYHA1402 in Healthy Chinese Subjects. Neurology and therapy 12 (3) (2023)
Beibei Liang, Jin Wang, Guanxuanzi Zhang, Rui Wang, Yun Cai
Safety, Tolerability and Pharmacokinetics of Single-Dose Oral SYHA1402 in Healthy Chinese Subjects. Neurology and therapy 12 (3) (2023)
Dominika Miszewska, Katarzyna Kotulska, Aleksandra Duda, Sergiusz Jozwiak
Effect of mTOR Inhibitors in Epilepsy Treatment in Children with Tuberous Sclerosis Complex Under 2 Years of Age. Neurology and therapy 12 (3) (2023)
Yijie Feng, Yiqin Cui, Jianing Jin, Siyi Huang, Jia Wei, Mei Yao, Dongming Zhou, Shanshan Mao
The Alterations of Gut Microbiome and Lipid Metabolism in Patients with Spinal Muscular Atrophy. Neurology and therapy 12 (3) (2023)
Dominika Miszewska, Katarzyna Kotulska, Aleksandra Duda, Sergiusz Jozwiak
Effect of mTOR Inhibitors in Epilepsy Treatment in Children with Tuberous Sclerosis Complex Under 2 Years of Age. Neurology and therapy 12 (3) (2023)

volume 12, number Suppl 1, 2023

Tung-Ping Su
Anxiety Symptoms in Depression: Contemporary Treatment Approaches. Neurology and therapy 12 (Suppl 1) (2023)
Malcolm Hopwood
Anxiety Symptoms in Patients with Major Depressive Disorder: Commentary on Prevalence and Clinical Implications. Neurology and therapy 12 (Suppl 1) (2023)
Chia-Ming Chang
What Do Patients Want in the Treatment of Major Depressive Disorder? Taiwan's TAILOR Survey. Neurology and therapy 12 (Suppl 1) (2023)
Malcolm Hopwood
Anxiety Symptoms in Patients with Major Depressive Disorder: Commentary on Prevalence and Clinical Implications. Neurology and therapy 12 (Suppl 1) (2023)
Dan J Stein
Evidence-Based Pharmacotherapy of Anxiety Symptoms in Patients with Major Depressive Disorder: Focus on Agomelatine. Neurology and therapy 12 (Suppl 1) (2023)
Chia-Ming Chang
What Do Patients Want in the Treatment of Major Depressive Disorder? Taiwan's TAILOR Survey. Neurology and therapy 12 (Suppl 1) (2023)
Malcolm Hopwood
Anxiety Symptoms in Patients with Major Depressive Disorder: Commentary on Prevalence and Clinical Implications. Neurology and therapy 12 (Suppl 1) (2023)
Chia-Ming Chang
What Do Patients Want in the Treatment of Major Depressive Disorder? Taiwan's TAILOR Survey. Neurology and therapy 12 (Suppl 1) (2023)
Dan J Stein
Evidence-Based Pharmacotherapy of Anxiety Symptoms in Patients with Major Depressive Disorder: Focus on Agomelatine. Neurology and therapy 12 (Suppl 1) (2023)
Tung-Ping Su
Anxiety Symptoms in Depression: Contemporary Treatment Approaches. Neurology and therapy 12 (Suppl 1) (2023)
Dan J Stein
Evidence-Based Pharmacotherapy of Anxiety Symptoms in Patients with Major Depressive Disorder: Focus on Agomelatine. Neurology and therapy 12 (Suppl 1) (2023)
Tung-Ping Su
Anxiety Symptoms in Depression: Contemporary Treatment Approaches. Neurology and therapy 12 (Suppl 1) (2023)